One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT

Background FAST-Forward aimed to identify a 5-fraction schedule of adjuvant radiotherapy delivered in 1 week that was non-inferior in terms of local cancer control and as safe as the standard 15-fraction regimen after primary surgery for early breast cancer. Published acute toxicity and 5-year resul...

Descripción completa

Detalles Bibliográficos

Autores principales:	Adrian Murray Brunt, Joanne S Haviland, Duncan A Wheatley, Mark A Sydenham, David J Bloomfield, Charlie Chan, Suzy Cleator, Charlotte E Coles, Ellen Donovan, Helen Fleming, David Glynn, Andrew Goodman, Susan Griffin, Penelope Hopwood, Anna M Kirby, Cliona C Kirwan, Zohal Nabi, Jaymini Patel, Elinor Sawyer, Navita Somaiah, Isabel Syndikus, Karen Venables, John R Yarnold, Judith M Bliss
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	NIHR Journals Library 2023-11-01
Colección:	Health Technology Assessment
Materias:	adult breast neoplasms cost-benefit analysis humans patient-reported outcome measures radiation dose hypofractionation radiotherapy adjuvant relapse united kingdom phase iii randomised non-inferiority trial
Acceso en línea:	https://doi.org/10.3310/WWBF1044
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!